Connect
← Return to ARSI PR wars: Nubeqa (Bayer) vs Erleada (J & J) lawsuit
Discussion
ARSI PR wars: Nubeqa (Bayer) vs Erleada (J & J) lawsuit
Prostate Cancer | Last Active: 1 day ago | Replies (36)Comment receiving replies
They each have their safety profile.
It’s always difficult to extrapolate from a large population to what the outcome will be for one individual.
Replies to "They each have their safety profile. It’s always difficult to extrapolate from a large population to..."
Connect
@brianjarvis
I’ve heard from dozens of people that are on Nubeqa, I don’t think I’ve heard of fatigue being a problem more than once. In that case, it was somebody who stopped taking it and then started it again. Interesting that i’ve heard about fatigue from the other drugs, but it’s listed as less than 1%. Also interesting that Nubeqa is supposed to work better if you’re on chemo.
All of the side effects seem to affect less than 1% of the people using the drug, except cardiovascular with less than 4%.
The rash issue seems to be common among all of them. I have small little rashes all over my stomach really small. I have three or four spots where the skin turns a little brown and it’s itchy. I figured it had to be Nubeqa. I have to put Triamcinolon on three spots almost every day or it starts to itch. Fortunately, my dermatologist has allowed me to order this repeatedly.
Interesting tables.